Optic Neuritis Completed Phase 2 Trials for Erythropoietin (DB00016)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00355095Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic NeuritisPrevention